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Abstract
Background: Xylanases deserve particular attention due to their potential application in the feed, pulp bleaching and paper
industries. We have developed here an efficient system for the production of an active xylanase in tobacco plants fused to a
proline-rich domain (Zera) of the maize storage protein c-zein. Zera is a self-assembling domain able to form protein
aggregates in vivo packed in newly formed endoplasmic reticulum-derived organelles known as protein bodies (PBs).
Methodology/Principal Findings: Tobacco leaves were transiently transformed with a binary vector containing the Zera-
xylanase coding region, which was optimized for plant expression, under the control of the 35S CaMV promoter. The fusion
protein was efficiently expressed and stored in dense PBs, resulting in yields of up to 9% of total protein. Zera-xylanase was
post-translationally modified with high-mannose-type glycans. Xylanase fused to Zera was biologically active not only when
solubilized from PBs but also in its insoluble form. The resistance of insoluble Zera-xylanase to trypsin digestion
demonstrated that the correct folding of xylanase in PBs was not impaired by Zera oligomerization. The activity of insoluble
Zera-xylanase was enhanced when substrate accessibility was facilitated by physical treatments such as ultrasound.
Moreover, we found that the thermostability of the enzyme was improved when Zera was fused to the C-terminus of
xylanase.
Conclusion/Significance: In the present work we have successfully produced an active insoluble aggregate of xylanase
fused to Zera in plants. Zera-xylanase chimeric protein accumulates within ER-derived protein bodies as active aggregates
that can easily be recovered by a simple density-based downstream process. The production of insoluble active Zera-
xylanase protein in tobacco outlines the potential of Zera as a fusion partner for producing enzymes of biotechnological
relevance. Zera-PBs could thus become efficient and low-cost bioreactors for industrial purposes.
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Introduction
Enzymes are currently used in several industrial products and
processes and new areas of applications are constantly being added.
Thanks to advances in biotechnology, novel technical enzyme
production technologies offer great potential for many industries
including the pulp and paper industry, feed and food industry,
biofuel production and the textile industry [1]. Technical enzymes
canbeusedaspurifiedenzymes,partiallypurifiedenzymesorwhole
cells containing functional catalytic activities and are often obtained
from a natural source or by recombinant expression in bacteria or
yeast. There is also increasing interest in the use of plants as host
expression systems for technical enzymes because their production
can be easily scaled up with low production costs [2,3].
Xylanases are bacterial enzymes that degrade xylans, breaking
down hemicelluloses, which are one of the major components of
plant cell walls. Xylanases are fast becoming a major group of
industrial enzymes, with significant application in feed, pulp
bleaching and paper industry [4]. Many different technologies have
been developed to produce xylanases in plants using stable
transformation methods. Bacterial xylanases for bio-bleaching and
baking applications have been expressed in transgenic rice [5]
barley [6] and Arabidopsis, targeted either to peroxisomes or
chloroplasts, or at both organelles simultaneously [7–9]. Attempts
to produce xylanases in the plant root exudates of transgenic
tobacco plants [10] and in transgenic potato plants [11] have also
beenmade.However,inall casesthe levelofenzymeactivitywas far
below that required industrial application. Recently, approaches to
producing industrial enzymes for the degradation of lignocellulosic
biomass have focused on generating crop varieties that self-produce
and store degrading enzymes. In this context, a bacterial xylanase
was expressed in the endosperm of wheat seeds [12] but the wheat
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expression of thermophilic enzymes that are inactive at ambient
temperatures is an alternative approach to overcome the detrimen-
tal effects that were encountered when active cell-wall hydrolytic
enzymes accumulated in the apoplast. Recently, two thermophilic
bacterial xylanases targeted to the apoplast were expressed in
Arabidopsis thaliana, and transgenic plants appeared phenotypically
normal and fully fertile. Both xylanases were preserved in dried
Arabidopsis stems with very low activities at 40uC but were active at
85uC and interestingly, extracts from dry stems showed a decrease
in the molecular weight of xylans after heat treatment [13].
When using plants as a host for the expression of industrial
enzymes three main factors are decisive in determining their
commercial viability: i) high levels of expression ii) efficient
downstream processing and iii) operational stability of enzymes.
High expression levels have been obtained by using fusion protein
technologies such as elastin-like polypeptides (ELPs) [14–16],
hydrophobin [17], zeolin [18] and Zera, a proline-rich domain of
the maize storage protein c-zein [19]. All these fusion proteins
when expressed in plants are encapsulated in ER-derived PBs.
ELPs fusions proteins are recovered as soluble recombinant
protein by a non-chromatographic separation method termed
inverse transition cycling (ITC) [20], hydrophobin fusions by two-
phase procedures [17] and Zera fusions by density-based methods
[21]. The oleosin fusion expression system is another example of
fusion technology that has been used to produce recombinant
proteins on the surface of oil bodies, which can be separated by
flotation from an aqueous extraction of seed biomass [22].
Cost-effective manufacturing of bulk enzymes requires a simple
and rapid downstream processing of the bioactive enzyme
preparations and a functional operational stability of the enzymes.
In the last decade, immobilized and insoluble enzymes prepara-
tions have emerged as the optimum methodology to enhance
operational performance of biocatalysts [23,24]. In this regard, the
ability of the proline-rich domain of c-zein (Zera) to pack fusion
proteins as insoluble aggregates within PBs [25] appears as a
desirable attribute to produce industrial enzymes.
Ouraiminthe presentstudyistoexplore the applicabilityofZera
attributes to produce bioactive industrial enzymes in plants in their
insoluble form. A xylanase mutant [26] of Streptomyces olivaceoviridis
XYNB xylanase [27] was chosen as an industrial enzyme model.
We show that xylanase fused to Zera (Zera-Xyl) is highly expressed
in Nicotiana benthamiana transiently transformed leaves, accounting
for up to 9% of the total soluble proteins. The Zera-Xyl fusion
protein accumulates in dense protein bodies and the enzyme is post-
translationally modified with ER maturation-type glycans. We
demonstrate that, after its recovery simply by centrifugation, the
insoluble polymer of Zera-Xyl is biologically active and shows stable
activity for at least one month at room temperature.
Results
Transient expression of xylanase fused to a proline-rich
domain (Zera) in tobacco leaves
A codon-optimized XYNTB synthetic gene from Streptomyces
olivaceoviridis [26] was fused at its N-terminus to the DNA sequence
coding the signal peptide and proline-rich domain of c-zein (Zera).
The entire chimeric Zera-XYNTB gene (Zera-Xyl) was inserted
into the plant binary expression vector pCambia 2300 under the
control of the enhanced cauliflower mosaic virus (CaMV) 35S
promoter, a TEV translational enhancer and the 35S terminator
(Figure 1A, pCZera-Xyl construct). The construct was co-
agroinfiltrated into Nicotiana benthamiana leaves together with a
vector containing the coding sequence of the HcPro protein, a
suppressor of silencing [28]. Transiently transformed N. benthamiana
leaves were collected at 3, 5, 7 and 10 days post infiltration (dpi).
Leaves transformed only with the silencing suppressor were used as
controls. Coomassie staining of proteins resolved in electrophoretic
gels showed several abundant bands ranging from 38 to 44 kD in
protein extracts from leaves that had been transformed with the
pCZera-Xyl construct (Figure 1B). The observed bands had a
higher molecular mass than the 36 kD expected for the Zera-Xyl
fusion protein. The identity of the fusion protein was established
using polyclonal antibodies directed either against Zera (anti-R8
antibody) [19] or xylanase. Polyclonal antibodies against xylanase
were raised in rabbits immunized with pure XYNTB expressed in
E. coli. The western blot analysis of protein extracts from
transformed leaves confirmed that the highly abundant bands
corresponded to different forms of Zera-Xyl (Figure 1C and D,
respectively). Because xylanase has three consensus N-glycosylation
sites, the microheterogeneity detected is probably due to post-
translational modification, as demonstrated later. The Zera-Xyl
expression levels were determined by densitometry using an extract
of total proteins of tobacco leaves transformed only with HcPro as
reference. As shown in Figure 1E, the accumulation levels of Zera-
Xyl isoforms, which were visualized by Coomassie staining as early
as 3 dpi (Figure 1B), clearly increased up to 7 dpi and remained
stable thereafter. According to the densitometry results, Zera-Xyl
accounted for 12% of the total protein resolved in the SDS-PAGE
(Figure 1B). However, quantification by densitometry only includes
some of the total protein, and therefore we estimate that the fusion
protein would account for approximately 9% of the total protein.
This would correspond to 1.6 g of Zera-Xyl/Kg fresh weight or
1.08 g of xylanase/Kg fresh weight.
Zera-xylanase protein accumulates in dense protein
bodies
We then explored the subcellular localization of the Zera-Xyl
fusion protein in tobacco leaf sections collected at 7 dpi. Immuno-
localization was performed by whole mounting using anti R8 as the
primary antibody and anti-rabbit IgG conjugated to Alexa Fluor 488
dye as the secondary antibody, with examination by confocal laser
scanning microscopy. A characteristic of Zera fusion proteins is their
ability to target and accumulate in PBs. As shown in Figure 2A,
tobacco epidermal cells displayed numerous spherical organelles with
diameters of 1–2 mm, similar in shape and size to the PBs previously
described for other Zera fusions proteins [19,25]. The bright green
fluorescence was only observed in the periphery of the PB. This could
be due to Zera domain polymerization [25], making the highly
packed PBs inaccessible to the antibody.
The next step was to test whether the Zera-Xyl-accumulating
organelles were dense, as has been described for a variety of Zera
fusions [19,25,29]. To characterize the density of the PB-like
structures accumulating Zera-Xyl, we analyzed Zera-Xyl-express-
ing leaf homogenates by subcellular fractionation using Iodixanol-
based density step gradients (Optiprep) [21]. Equivalent amounts
of collected fractions were analyzed by gel electrophoresis followed
by Coomassie blue staining and immunoblot analysis using the
anti-Xylanase antibody. As shown in Figure 2 (B,C), most of the
Zera-Xyl protein was recovered in the dense 1.21–1.23 g/cm3
(F4) and 1.23–1.25 g/cm3 (F5) interfaces of the gradient,
confirming the expected high density of the new induced
organelles. The high molecular weight immunoreactive bands
that were detected in the homogenate and in the dense fractions
are likely to correspond to dimers and trimers of Zera-Xyl. We
then investigated whether Zera-Xyl microheterogeneity, which
was also observed in dense PBs, was the result of xylanase
posttranslational modifications such as glycosylation.
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glycosylated with high mannose-type glycans
The XYNTB xylanase sequence contains three potential
glycosylation sites but Zera has no consensus site for N-
glycosylation. Therefore, the microheterogeneity of Zera-Xyl
bands observed in the electrophoretic pattern (Figure 1) prompted
us to investigate whether the xylanase was glycosylated when
expressed as the Zera-Xyl fusion and accumulated in PBs. To
determine the presence of glycans and their structure, PBs were
recovered from Zera-Xyl-transformed leaves and were treated
Figure 1. Transient expression of Zera-Xyl in Nicotiana benthamiana leaves. (A) Schematic representation of plant expression vector
encoding for Zera xylanase fusion under the control of the enhanced cauliflower mosaic virus 35S promoter, a translational enhancer of tobacco etch
virus (TEV) and the cauliflower mosaic virus 35S terminator (pCZera-Xyl). The Zera sequence includes the signal peptide and the first 112 amino acid
coding region of c-zein. (B) Coomassie-stained SDS-PAGE analysis of protein extracted from N. benthamiana leaves co-infiltrated with Zera-Xyl and
the silencing suppressor HcPro. Leaf tissue was collected at 3 (lane 1), 5 (lane 2), 7 (lane 3) and 10 (lane 4) days post infiltration (dpi). Leaves
agroinfiltrated only with HcPro (lane 5) were used as control. Gels were loaded with 20 mg of total protein and stained with Coomassie blue. Arrows
indicate the molecular weight window of the multiple bands of Zera-xylanase. (C–D) Immunoblots blots were incubated with xylanase antibody (C)
and with an antibody against Zera (R8 antibody) (D). In immunoblots, gels were loaded with 2.5 mg of total protein. (E) Levels of Zera-Xyl protein
accumulation (%) relative to the total protein determined by densitometric analysis of Coomassie-blue-stained SDS-PAGE gels. Data were quantified
with Multi Gauge v.3.0. The relative accumulation of Zera-Xyl was calculated on the basis of the total protein loaded in each lane corresponding to 3,
5, 7 and 10 dpi. The results represent the average of at least three independent protein extracts.
doi:10.1371/journal.pone.0019474.g001
Active Xylanase Aggregates in Plants
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e19474with Endo H and PNGase F glycosylases followed by SDS-PAGE
and western blot analysis using the R8 antibody. As a non-
glycosylated control, a preparation of PBs from Zera-ECFP-
transformed leaves was treated with the two glycosylases in the
same conditions. After treatment with Endo H and PNGase F, the
broad band of Zera-Xyl showed a mobility shift as well as a
reduction in the number of electrophoretic bands (Figure 3, lanes
1–3). Xylanase was sensitive to both Endo H and PNGase F. The
smaller bands of about 36 kDa generated after enzymatic
processing corresponded to the expected apparent molecular
weight for the unglycosylated Zera-Xyl fusion. As expected, non-
glycosylated Zera-ECFP was not sensitive to Endo H or PNGase F
(Figure 3, lanes 4–6). The abundant bands of 60 kDa and 32 kDa
observed in the Coomassie-blue-stained electrophoretic gels
corresponded to Endo H and PNGase F respectively (Figure 3A
arrowheads). These results reveal that the N-linked glycans of
Zera-Xyl had high mannose structure, indicative of its localization
in the ER [30], and also indicate that the addition of these glycans
does not impair the self-assembly and polymerization of Zera that
is required for PB formation.
Xylanase activity is not compromised by the fusion with
Zera
As Zera fusions accumulate as large oligomers inside the PBs
due to Zera oligomerization, we attempted to determine xylanase
activity after solubilizing the Zera-Xyl polymers from PBs. The
purity of the recombinant protein was assessed by Coomassie
staining of proteins resolved in a SDS-PAGE gel (Figure 4A) and
the protein concentration was evaluated using the EZQ Protein
Quantitation Kit (Molecular Probes). As shown in Figure 4A,
protein extraction from a PB suspension (lane 1) in aqueous buffer
in the presence of 0.02% SDS and 5 mM of reducing agent
(TCEP, Tris(2-carboxy-ethyl)phosphine hydrochloride) was suffi-
cient to solubilize most of the Zera-Xyl present in the PBs
(Figure 4A, lanes 2 and 3). After dialysis in 200 mM phosphate
citrate pH 6 buffer, appropriate dilutions of soluble protein were
used for the activity assay (EnzChek Ultra Xylanase Assay Kit,
Molecular Probes). As a positive control, XYNTB xylanase
bearing a His tag expressed in E. coli (rXylanase) and purified by
Figure 2. Zera-Xyl is stored in dense PBs. (A) Whole mount
immunolocalization of Zera-Xyl in N. benthamiana leaves at 7 days after
agroinfiltration. R8-antibody (1:8000 dilutions) was used as the primary
antibody and anti-rabbit IgG conjugated to Alexa Fluor 488 dye was
used as the secondary antibody. In the confocal optical section on the
left, white arrows indicate a couple of PBs immunolabelled in green. On
the right, the black arrows in the transmission picture indicate the same
PBs. (B–C) The density of Zera-Xyl-induced PBs was assessed by loading
N. benthamiana homogenates onto a multi step Iodixanol density-
based gradient (steps: 1.11, 1.17, 1.19, 1.21, 1.23, 1.25 g/cm
3). Proteins
in the homogenate (H), supernatant (S), fractions of increasing density
(F1–F5) and pellet (P) were resolved in SDS-PAGE and stained with
Coomassie blue (B) or analyzed by immunoblot (C). Immunoblot was
probed with the Xyl antibody. Multiple immunoreactive forms of Zera-
Xyl were recovered mainly in the F5 fraction (d; 1.233 g/cm
3) but also in
the dense fraction F4 (1.214 g/cm
3). Arrows indicate the recombinant
Zera- Xyl fusion protein.
doi:10.1371/journal.pone.0019474.g002
Figure 3. Glycosylation of Zera-Xyl. PB extracts prepared from
Zera-Xyl transformed leaves were digested with Endo H and PNGase F
as indicated and analyzed by gel electrophoresis stained with
Coomassie blue. Non-digested Zera-Xyl was used as a reference (lane
1). The Zera-ECFP fusion was also digested with both glycosylases (lanes
4–6) as a control of non-glycosylated protein. Zera-Xyl bands were
sensitive to both Endo H and PNGase F. The bands shifted to lower
molecular weight bands (lanes 2 and 3 and arrows), whereas the
unglycosylated Zera-ECFP protein was resistant to digestion (lanes 5
and 6). Lower panel: immunoblots using R8 antibody. Arrowheads
indicate the electrophoretic bands of Endo H and PNGase F.
doi:10.1371/journal.pone.0019474.g003
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controls were also included, such as the commercial xylanase from
Trichoderma viride (Sigma) as a positive control and a Zera fused to
human growth hormone (Zera-hGH) solubilized from PBs as a
negative control.
Conversion of the substrate to the fluorescent product was
measured at different time points every 2 minutes over a period of
30 minutes. The accumulation of fluorescent product using
different amounts of Zera-Xyl revealed that Zera-Xyl solubilized
from PBs was highly active. The rate of product formation per
minute, determined according to the increase in fluorescence
between the first two time points (2 to 4 min), was shown to have a
linear correlation with the amount of enzyme used in the reaction
over a range of 2.5 to 80 ng of Zera-Xyl (Figure 4C). The affinity
of Zera-Xyl for the substrate was determined by measuring the
rate of product formation at increasing concentrations of substrate
(Figure 4D). The Michaelis-Menten constant (Km) of Zera-Xyl was
0.46 mM, which is lower than that reported for another xylanase
using the same synthetic substrate [31]. The specific activity of
Zera-Xyl solubilized from isolated PBs yields an average of
5.5 nmol/min/mg of fusion protein. This result was similar to the
enzyme activity measured in rXylanase expressed in E. coli
(10.2 nmol/min/mg protein) and commercial Trichoderma viride
xylanase (2.3 nmol/min/mg of protein) using the same assay
conditions. When expressed on the basis of fresh weight tobacco
biomass, PBs isolated from 1 g of fresh tissue yielded enough
soluble recombinant Zera-Xyl to produce an average of 3.3 mmol
of product per min. As expected, no xylanase activity was detected
in Zera-hGH used as negative control (not shown). These results
indicated that xylanase activity was not essentially affected by the
presence of Zera, suggesting that this proline-rich domain, when
fused to the N-terminus of the enzyme, interferes little with the
folding and the affinity for the substrate.
Protein bodies as bioactive organelles
With regards large-scale downstream processing of the protein,
solubilization of the fusion protein could be an inefficient step.
Therefore, we investigated whether Zera-Xyl was active in the
oligomerized-insoluble form accumulated in PBs. To this end, PBs
isolated from transformed leaves (see experimental procedures)
were used directly for xylanase activity assays, avoiding prior
solubilization of the recombinant protein. After washing of PBs,
the large oligomers of Zera-Xyl recovered by centrifugation were
maintained in a homogeneous suspension in the activity buffer by
continuous shaking of the sample. Dilutions of the insoluble Zera-
Xyl suspension were submitted to a xylanase activity assay by
adding the synthetic substrate and measuring the fluorescent
product. Interestingly, Zera-Xyl large oligomers (named insoluble
Zera-Xyl) were also active, generating around 0.26 mmol of
product/min/g FW (Figure 5A). However, the activity recovered
per gram of fresh tissue was rather much lower than that obtained
with solubilized Zera-Xyl. The reduced xylanase activity obtained
from insoluble Zera-Xyl compared with that of solubilized Zera-
Xyl could be due to the oligomerization process of Zera. Two
main factors could explain the reduction in xylanase activity: i) the
low accessibility of the substrate to the enzyme and ii) disruptions
in the structure of the enzyme that would result in the presence of
inactive forms of xylanase in PBs.
To explore these possibilities, we first considered the improve-
ment of substrate accessibility to the enzyme by physical
treatments such as directly applied sonication and immersion in
ultrasound-bath. The application of both physical treatments to
the polymer of Zera-Xyl resulted in a dramatic increase in
xylanase activity (Figure 5A), reaching activity levels per gram of
Figure 4. Activity of Zera-Xyl solubilized from PBs. (A) Gel
electrophoresis analysis of Zera-Xyl fusion protein present in PBs
isolated from transformed tobacco leaves (lane 1). Zera-Xyl solubilized
from PBs in 0.02% SDS, 5 mM TCEP for 2 h at room temperature (lane
2). Fusion protein that remained insoluble after treatment (lane 3)
Arrows indicate monomers and oligomers of Zera-Xyl. (B) rXylanase
expressed in E. coli BL21 strain. Analysis of total proteins of cell extracts
analyzed by gel electrophoresis after the induction of expression with
1 mM IPTG for 5 h at 37uC (lane 1, arrowhead). Recombinant xylanase
purified by Ni+ affinity column (lane 2). (C) Increasing amounts of
solubilized Zera-Xyl were assayed for enzymatic activity and the
product measured at 2 min intervals. For each Zera-Xyl concentration,
the increase in product between 2 and 4 min was used to calculate the
rate of product/min. (D) Determination of Michaelis-Menten constant
(Km) of Zera-Xyl solubilized from PBs. Graphical representation of
velocity (pmol/min) as a function of the substrate concentration [S]
(mM DiFMUX2).
doi:10.1371/journal.pone.0019474.g004
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The Michaelis-Menten constant (Km) of insoluble Zera-Xyl was
1.19 mM (Figure 5B), substantially higher than that determined
in soluble Zera-Xyl. Sonication treatment improved substrate
accessibility but did not cause the Zera-Xyl polymer solubilization,
as deduced from the absence of xylanase activity in the
supernatants after centrifugation of the sonicated Zera-Xyl
suspension.
Figure 5. Activity of insoluble Zera-Xyl. (A) Insoluble Zera-Xyl was submitted to direct ultrasound or water-bath ultrasound before the enzymatic
assay. Xylanase activity is referred to in mmol of product/min/g FW. (B) Determination of Michaelis-Menten constant (Km) of insoluble Zera-Xyl from
PBs. Graphical representation of velocity (pmol/min) as a function of the substrate concentration [S] (mM DiFMUX2). (C) Zera-Xyl resistance to trypsin
digestion. Zera-Xyl suspension was treated with trypsin at a trypsin:Zera-Xyl ratio of 1:200 (w:w). Lane 2 represents time 0 of digestion. Two controls
were included in the trypsin reactions: a Zera-Xyl suspension thermally denatured at 90uC for 20 min prior to trypsin treatment (lanes 5–8), and a
suspension of Zera-hGH PBs isolated from Zera-hGH agroinfiltrated leaves (lanes 9–12). Trypsin reactions were carried out at 37uC for 0 h (lanes 2, 6
and 10), 1 h (lanes 3, 7 and 11) and 2 h (lanes 3, 7 and 12). Protein profiles were analyzed by gel electrophoresis stained with Coomassie blue.
doi:10.1371/journal.pone.0019474.g005
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contained a mixture of folded active and unfolded inactive forms
of xylanase. To answer this question, we took advantage of the fact
that the Zera peptide is resistant to trypsin proteolysis and that the
activity of native xylanase XYNB is 100% resistant to trypsin
digestion [32]. A suspension of insoluble Zera-Xyl prepared from
PBs was digested with trypsin at pH 8 (Figure 5C, lanes 1–4). As
controls, two additional digestions were carried out: the digestion
of a suspension of Zera-Xyl previously treated at 90uC which
denatured xylanase (Figure 5C, lanes 5–8) and the digestion of a
suspension containing Zera fused to a trypsin sensitive protein
such as human growth hormone (hGH) [33] (Figure 5C, lanes 9–
12). As shown in Figure 5C (lanes 1–4) the protein profile of Zera-
Xyl was not affected after 2 h of trypsin digestion (Figure 5C, lane
4), indicating that xylanase was resistant to the protease. In
contrast, protein digestion was observed after 1 h of trypsin
treatment in denatured Zera-Xyl (lane 7) and in Zera-hGH (lane
11). Moreover, the insoluble enzyme fully retained its original
activity after 2 h digestion at 37uC (Table 1). However, prior
treatment of Zera-Xyl at 90uC for 20 minutes resulted in the
complete loss of activity (Table 1), indicative of effective
denaturation of the enzyme, which was accompanied by xylanase
susceptibility to proteolytic digestion. Altogether, these results
indicated that the folding of xylanase was not disrupted by the
polymerization of Zera. Therefore, Zera-Xyl-induced PBs essen-
tially contained biologically active xylanase protein.
Stability of Zera xylanase activity
We also explored the stability of Zera-Xyl aggregates during
storage at different temperatures. To this end, a freshly prepared
Zera-Xyl suspension was divided into several aliquots that were
kept either at RT, 4uCo r220uC for 9 or 35 days (Figure 6A). Our
results indicate that the activity of insoluble Zera-Xyl is preserved
for at least 35 days at both room temperature and at 4uC.
Although a decrease in activity was observed at freezing
temperatures, the enzyme retained more than the 80% of its
activity at 220uC.
A bottleneck in the use of xylanases for industrial applications is
the resistance of the enzyme to high temperatures [4]. Since the N-
terminus of xylanase is involved in thermostability [26], two Zera
protein fusions were used to study the effect of high temperatures
on the activity of xylanase fused to Zera: Zera-Xyl and Xylanse-
Zera-KDEL (Xyl-Zera-KDEL). This second construct allowed the
enzyme to maintain the N-terminus free of fusion with Zera and,
moreover, took advantage of the fact that PBs were also induced
when Xyl-Zera-KDEL was expressed in tobacco leaves. Both the
level of protein accumulation and efficiency of PB recovery of Xyl-
Zera-KDEL were similar to those detected in Zera-Xyl (not
shown). Insoluble Zera-Xyl and Xyl-Zera-KDEL preparations
were incubated for 20 min at 50uC, 60uC and 70uC before the
activity assay (Figure 6B). rXylanase expressed in E. coli was
included as a positive control. In order to detect variations in
activity, activity at room temperature was designed as 100% of
activity. Under standard assay conditions, Zera C-terminal fusions
improved thermostability, Zera-Xyl lost 70% of its activity after
treatment at 60uC whereas the activity of Xyl-Zera-KDEL was
reduced by only 25%. Moreover, Xyl-Zera-KDEL retained 50%
of its activity after treatment at 70uC but Zera-Xyl was not
resistant in these conditions. In the absence of Zera, rXylanase
expressed in E. coli was fully active after 20 min at either 60uCo r
70uC (Figure 6B) but lost its activity at 90uC (not shown).
Discussion
In this study, we show that a fusion strategy can be very efficient
at producing industrial enzymes in plants. A bacterial xylanase,
used as a model enzyme, was fused to a proline-rich domain of c-
zein, which has the capacity to self-assemble in vitro [34] and in
transgenic plants [35]. When this proline-rich domain (named
Zera) was fused to target proteins it was also able to self assemble
and to form large polymers inside the ER-derived PBs. The
recombinant protein fusions remained encapsulated and sur-
rounded by ER membrane. Subsequently, protein targeting to this
Table 1. Resistance of Zera-Xyl to trypsin digestion.
Relative xylanase
activity
Zera-Xyl undigested 100
Zera-Xyl Trypsin
digested
Non-Denaturing
Treatment
0h 106±14
2h 98±10
Denaturing Treatment 0 h 0.3
2h 0.3
A suspension of Zera-Xyl was digested with trypsin for 2 h at a trypsin:Zera-Xyl
ratio of 1:200 (w:w). Prior digestion, Zera-Xyl was either non-denatured or
denatured by treating at 90uC. Xylanase activity was measured prior and after
trypsin digestion.
doi:10.1371/journal.pone.0019474.t001
Figure 6. Operational stability and thermostability of insoluble
Zera-Xylanase. (A) Measurement of Zera-Xyl activity at day 0, after 9
days and after 35 days at the temperatures indicated. (B) Thermosta-
bility of insoluble Zera-Xyl and insoluble Xyl-Zera-KDEL expressed in
tobacco leaves and purified soluble rXylanase expressed in E. coli.
Relative residual activity after incubation for 20 min at the temperatures
indicated before the activity assay. Activities at RT were designated as
100% activity. Error bars represent the relative standard deviations of
three independent replicates.
doi:10.1371/journal.pone.0019474.g006
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high levels of accumulation of recombinant protein [19]. It has
previously been shown that, as occurs in natural PBs from maize
seeds [36], Zera-induced PBs in tobacco leaves can easily be
recovered by density [21].
Our aim in using Zera fusions in this study was to produce
active xylanase in plant PBs. Zera-Xyl constitutively expressed in
Nicotiana benthamiana leaves increased the production of the
enzyme. The Zera-Xyl fusion protein in total protein extracts
was clearly detected until 10 dpi in electrophoretic gels stained
with Coomassie blue. We estimated that the amount of Zera-Xyl
in transformed leaves collected at 7 dpi represents up to 9% of the
total protein. There is evidence that transient transformation of
tobacco leaves is a very efficient system for producing rapid and
scalable high rates of recombinant proteins [37]. The stability of
the mRNA of Zera fusions determines, however, the period of
time over which the protein is translated, oligomerized and
accumulated in PBs. When using the agroinfiltration technique in
transient transformations in tobacco, the mRNA of Zera fusions
usually decayed after 7 dpi [25]. We have evidence that Zera
fusion proteins are essentially stably accumulated in tobacco plants
[19], and therefore levels of Zera-Xyl protein in transiently
transformed tobacco leaves are likely to be regulated mainly by the
stability of its RNA and enzyme accumulation in PBs.
As previously demonstrated for Zera protein fusions expressed
in plants and in non-plant hosts [19], the storage of Zera-Xyl in
dense ER-derived PBs favors its easy recovery by low-speed
centrifugation. Targeting of recombinant proteins to ER-derived
PBs has also been described using fusions of the target protein to
ELP [16] and hydrophobins [17] In these two cases, however, the
PBs formed were not dense, and therefore the recombinant
protein had to be recovered by other means such as inverse
transition cycling (ITC) and two-phase procedures. In order to
improve recombinant xylanase production, several studies have
considered xylanase expression targeted to different organelles. To
date, the highest xylanase accumulation in leaves has been
obtained by expressing xylanase targeted to the chloroplast [7].
We show here that Zera-Xyl fusion emerges as a powerful tool to
produce this enzyme.
In our study, Zera-Xyl was not expressed as in a unique protein
form. To our knowledge, the Zera domain is not glycosylated but
the XYNTB xylanase amino acid sequence has three potential N-
glycosylation sites that were glycosylated when expressed in Pichia
pastoris [27]. A bacterial xylanase, similar to that used in this study,
was also glycosylated when expressed in the apoplast of transgenic
potato plants [11]. Zera-Xyl digestions with Endo H and PGNase
F indicate that xylanase was glycosylated in PBs with high
mannose-type glycans, consistent with its residence in the ER. The
observed microheterogeneity of Zera-Xyl bands (ranging from
38 kDa to 44 kDa) suggests that after the transfer of the
oligosaccharide precursor Glc3Man9GlcNAc2 onto the nascent
Zera-Xyl, the kinetics of oligomerization of Zera inside the lumen
of the ER [25] could determine the accessibility of glucosidases
and glycosyltransferases [38] to the enzyme and, as result, the
xylanase in PBs is trimmed with different N-glycan structures.
Although complete N-glycans maturation would be impaired
during the insolubilization of the enzyme within the ER, it should
be noted that we did not observe degradation of the glycosylated
fusion protein. It is likely that glycosylated Zera fusion proteins
escaped the misfolded protein degradation pathway [39] avoiding
binding to the calnexin/calreticulin folding cycle, or by saturation
of the Hrd1/Yos9p-dependent ERAD pathway [40] due to the
early formation of oligomers.
Zera-Xyl was stored in PBs as an insoluble protein, and hence
we had two options for confirming its biological activity from a PB
preparation: i) in solubilized Zera-Xyl samples or ii) in a
suspension of insoluble Zera-Xyl directly prepared from PBs.
The specific activity of solubilized Zera-Xyl yields an average of
5.5 nmol/min/mg of fusion protein, which is similar to that
measured for the same xylanase expressed in E. coli. A more
relevant finding was that insoluble Zera-Xyl was also active and
that its activity was stable for at least a month at room
temperature, indicating that, after a low-speed centrifugation of
the biomass, PB preparations can be stored without requiring
immediate processing. During the short downstream processing of
tobacco biomass, we demonstrated that it is necessary to introduce
an additional step consisting in ultrasound treatment. The
accessibility of the substrate after this physical treatment restored
the activity found in solubilized Zera-xylanase per gram of fresh
tissue.
Thermostability is an important feature of xylanases for their
industrial applications [4,41] and is defined as the capacity of an
enzyme to remain stable and active after being submitted to high
temperatures (i.e. 70uC). The Streptomyces olivaceoviridis xylanase
gene used in this work had been previously improved for its
thermostability [27] by the substitution of the first 33 amino acids
of the N-terminus with the 31 amino acids of a xylanase gene of
Termomonospora fusca [26,42]. We show that the fusion of Zera at
the N-terminus of the enzyme leads to loss of thermostability
relative to the fusion-free xylanase. Thus, rXylanase expressed in
E. coli fully retained its activity at 60uC whereas Zera-Xyl lost
70%. Fusions of xylanase with Zera at the C-terminus containing a
KDEL extension partially resolved the loss of activity. The
recombinant Xyl-Zera-KDEL protein that also accumulated in
PBs as an insoluble protein retained 75% of its activity after
treatment at 60uC. Although this is a significant improvement,
engineering of a modified xylanase should be carried out to
optimize the use of Zera fusions in industrial applications.
Recently, a systematic mutagenesis study on the N-terminus of
the XYNB xylanase of Streptomyces olicaceoviridis showed that rather
than a N-terminal replacement, substitution of a few critical
residues dramatically improves xylanase thermostability [43].
XYNB xylanase is resistant to trypsin and pepsin digestion [27].
Trypsin digestion of Zera-Xyl allowed us to determine whether
xylanase fused to Zera was active and, consequently properly
folded. Both Zera-Xyl protein and xylanase activity were resistant
to trypsin digestion. As the Zera domain has no trypsin-cleavable
sites, the results suggest that if xylanase is not digested it should be
properly folded when it is fused to Zera and accumulated in
tobacco PBs. Thus, the self-polymerization process of Zera by
hydrophobic interactions and disulfide bond cross-linking does not
interfere during the folding process of the enzyme. The 3D
structure of G11 xylanases including XYNTB xylanase, comprises
two twisted b-sheets forming a so-called jellyroll, one a-helix and a
region containing two glutamic acid residues between the two b-
sheets that build the active and the substrate binding sites [44].
Although Zera-Xyl seemed to be properly folded, the affinity of
insoluble Zera-Xyl for the substrate was lower than that measured
in solubilized Zera-Xyl. In the light of this result we hypothesize
that the protein concentration in the large Zera-Xyl oligomers
impairs the conformational fluctuations, namely ‘‘breathing’’ [45],
which would be needed to accommodate the substrate in the
optimum environment. This result was not unexpected because in
insoluble enzymes the diffusion rates of substrates through the
aggregate may be limited [46]. We are currently engineering more
swollen Zera-Xyl polymers to improve enzyme efficiency.
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To conclude, the present work outlines the production of a
xylanase fused with a proline-rich domain (Zera) that is able to
form large insoluble oligomers in planta. The production of fusion
protein reached 1.6 g of Zera xylanase/kg, which corresponds to
1.08 g of xylanase/Kg of biomass. Xylanase in fusion was
glycosylated, trimmed with N-type glycans and accumulated
within dense ER-derived PBs in tobacco cells. The polymer of
Zera-Xyl can easily be recovered by density means in a simple
downstream process. Our successful production of insoluble active
Zera-xylanase in tobacco demonstrated the feasibility of this
approach for producing multiple enzymes of biotechnological
relevance inside PBs. Zera-PBs could thus become efficient and
low-cost bioreactors for industrial purposes.
Materials and Methods
Construction of plant expression vectors
A codon-optimized version of Streptomyces olivaceoviridis xylanase
XYNTB gene (GenBank accession number: DQ465452) preceded
by an enterokinase (EK) cleavage site was synthesized for tobacco
expression. NcoI and BamHI restriction sites in the synthetic gene
were used to replace ECFP in pUC18Zera-ECFP [19] with the
xylanase sequence (obtaining pUC18Zera-Xyl). The translational
fusion construct Zera-Xyl was inserted into the binary vector
pC2300 containing the enhanced 35S promoter, the tobacco etch
virus (TEV) translation enhancer and the 39 polyadenylation
sequences from the cauliflower mosaic virus (CaMV) yielding
vector pCZera-Xyl.
The Xylanase-Zera-KDEL construct was obtained by amplify-
ing SPg-Xylanase and Zera-KDEL coding sequences indepen-
dently by PCR. The xylanase fragment was amplified from
pUC18Zera-Xyl by PCR using 59 overlapping primers, which
introduced the c-zein signal peptide coding sequence (SPg)
preceded by a SalI restriction site, and a 39 reverse primer to
introduce an AscI restriction site. The resulting SPg-Xylanase
fragment was inserted in the binary vector pCZera-ECFP [25] by
SalI/AscI digestion to obtain the intermediate pCSPXyl-ECFP.
The Zera-KDEL moiety was amplified from pUC18Zera-ECFP
[19] using two overlapping 59 primers designed to amplify the
Zera sequence (lacking the signal peptide) preceded by an AscI
restriction site, a sequence coding for Lumiotag (CCPGCC) and a
sequence coding for five glycine residues (linker). The 39 reverse
primer introduced the KDEL and a BamHI restriction site. The
Zera-KDEL fragment was introduced into the intermediate
pCSPXyl-ECFP by AscI-BamHI to obtain pCSPXyl-Zera-KDEL.
The pCZera-hGH construct used as control was prepared as
described earlier [47].
To produce xylanase in E. coli, the xylanase coding sequence
flanked by NcoI and XhoI restriction sites was amplified by PCR
from pCZera-Xyl and inserted into the NcoI/XhoI digested
pET28b vector. The resulting vector, named pETXyl, contained
the XYNTB xylanase sequence fused in frame to the 59 His-tag
coding sequence of the vector.
Plant material and transient expression system
Leaves of 4–6-week-old Nicotiana benthamiana plants were
agroinfiltrated using the syringe method [48] with a culture of
Agrobacterium tumefaciens strain EHA 105 transformed with pCZera-
Xyl, pCSPXyl-Zera-KDEL, pCZera-ECFP [25] and pCZera-
hGH [47]. All transiently transformed leaves were co-infiltrated in
a 1:1 ratio with an Agrobacterium culture transformed with a
pCambia 2300 vector containing the HC-Pro silencing suppressor
[28].
Escherichia coli xylanase expression and anti-xylanase
antibody
Escherichia coli BL21 cells transformed with pETXyl were grown
to 0.5 OD and xylanase expression was induced with 1 mM IPTG
for 5 h at 37uC. The cells were lysed by sonication and the soluble
recombinant protein (rXylanase) was purified by Ni2+ affinity
chromatography (Chelating Sepharose Fast Flow, GE Healthcare).
The recombinant protein was eluted with 200 mM imidazole.
Purified rXylanase was dialyzed against 200 mM phosphate-
citrate buffer pH 6 for the activity assay and quantified using the
EZQ Protein Quantitation Kit (Invitrogen, Molecular Probes).
The polyclonal antibody against the enzyme was raised in rabbits
injected with the purified rXylanase. In immunoblots, anti-
xylanase antiserum was used at 1:2000 dilutions.
Protein extraction and immunoblot analysis
Proteins were extracted from 20 mg of agroinfiltrated leaf tissue
in 250 ml 50 mM Tris-HCl buffer pH 8, 200 mM NaCl, 1% SDS,
2% b-mercaptoethanol and protease inhibitors for 1 h at RT. The
resulting extracts were centrifuged at 100006g for 10 min at RT.
Protein extraction from untransformed leaves was also performed
under similar conditions. Protein extracts were quantified using
the Bradford reagent and analyzed by SDS-PAGE (12.5%
polyacrylamide). Proteins were detected by both Coomassie blue
staining and by immunoblot using either anti-R8 antibody [19] or
anti-xylanase antibody.
Endoglycosidase H and N-glycosidase F digestions
The Zera-Xyl protein obtained from PBs isolated by subcellular
fractionation was deglycosylated with Endo H (New England
Biolabs) or PNGase F (New England Biolabs) for 2 h at 37uC
according to the manufacturer’s instructions. As the unglycosy-
lated protein control, a Zera-ECFP protein suspension was also
digested with Endo H or PNGase F. Zera-Xyl and Zera-ECFP
protein samples treated in the same conditions but with no enzyme
were used as controls. Samples were analyzed by SDS-PAGE and
immunoblot using the anti-R8 antibody.
Immunocytochemistry and confocal microscopy
Whole mounting of wild type and agroinfiltrated leaves was
carried out as described previously [49]. Pieces of infiltrated leaves
were fixed in 4% paraformaldehyde with 0.1% Triton X-100 and
permeabilized in Driselase (Sigma) and IGEPAL CA-630 (Sigma)
plus 10% DMSO. For immunocytochemistry, the samples were
pre-blocked in 2% BSA and incubated with anti-R8 antibody
labelled with an anti-rabbit IgG conjugated to Alexa Fluor 488 dye
(Molecular Probes). Green fluorescent images were collected at a
wavelength of 488 nm excitation using an emission window set at
495 to 535 nm with a confocal laser scanning microscope
(Olympus FV1000).
Subcellular fractionation and protein body preparation
Subcellular fractionation in multi-step Iodixanol (Optiprep,
Sigma) density gradients was carried out essentially as described
previously [21].
Protein body preparation was performed from N. benthamiana
leaves transiently transformed with Zera-Xyl fusion constructs.
Four grams of leaf biomass were homogenized in 4 ml of cold
PBP3 buffer (100 mM Tris-HCL pH 8, 50 mM KCl, 6 mM
MgCl2, 10 mM EDTA, 0.4 M NaCl and protease inhibitors) at
room temperature and filtered through two layers of Miracloth
(22–24 mm, Calbiochem). The filtered homogenate was centri-
fuged at 15006g for 10 min at 4uC. The pellet containing PBs was
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supernatants were discarded. Washed PBs containing insoluble
Zera-Xyl fusion protein, were brought into suspension with 1 ml
of the appropriate enzyme activity buffer or resuspended in
Laemmli sample buffer for protein quantification analysis using
the EZQ Protein Quantitation kit (Invitrogen, Molecular Probes).
Xylanase activity assay
Xylanase activity was measured using an EnzChek xylanase
assay kit (Molecular Probes) according to the manufacturer’s
protocol. Briefly, washed Zera-Xyl and Xyl-Zera-KDEL PBs were
used directly or after sonication. Sonication was carried out in a
digital Sonifier (Branson Model 450) at 2 sec/pulse and 10%
amplitude for 30 sec on ice, or in ultrasound water bath (Selecta)
for 20 min at 4uC. Suspensions were stirred and serially diluted in
200 mM phosphate citrate buffer pH 6. Fifteen ml of each diluted
suspension were transferred to a 96-well ELISA plate and mixed
with 50 ml of 52.5 mM synthetic substrate DiFMUX2. Fluores-
cence was measured on a Synergy 2 Microplate reader (BioTek
Instruments, Inc., Winooski, VT) every 2 min for 30 min at
excitation/emission wavelengths of 360/40 nm and 460/40 nm,
respectively, acquired with Gene 5 software. Commercial xylanase
(Tricoderma viride, Sigma) and a washed PBs of Zera-hGH were used
as positive and negative controls, respectively.
To determine the activity of solubilized Zera-Xyl, freshly
prepared and washed PBs containing Zera-Xyl polymers were
solubilized in 200 mM phosphate citrate buffer pH 6, 0.02% SDS,
5 mM of Tris (2-carboxy-ethyl) phosphine hydrochloride (TCEP,
Sigma) and a cocktail of plant protease inhibitors (Sigma), with
shaking for 2 h at room temperature. After centrifugation at
100006g for 10 min, the supernatant was collected and dialyzed
against 200 mM phosphate citrate buffer pH 6. Protein quanti-
fication and the purity of dialyzed samples were evaluated prior to
preparation of serial dilutions in 200 mM phosphate citrate pH 6
for activity measurements. rXylanase and commercial xylanase
from Trichoderma viride (Sigma) were used as positive controls. For
determination of the Michaelis-Menten constant (Km), approxi-
mately 3 ng of soluble or insoluble but sonicated Zera-Xyl protein
were incubated with substrate concentrations ranging from 16 mM
to 2100 mM. The Michaelis-Menten constant (Km) was deter-
mined using Grafit32 software.
To evaluate storage stability, three replicates of protein
suspensions were sonicated and processed immediately to
determine activity at time 0 or were kept at different temperatures
(RT, 4uCo r220uC) for 9 and 35 days. After the storage period,
activity was measured as described above. To evaluate thermo-
stability, three replicates of sonicated suspensions were maintained
at RT, 50uC, 60uCo r7 0 uC for 20 min before being transferred to
ice and analyzed for activity.
Trypsin digestions
The sensitivity of Zera-Xyl to tryptic digestion was determined
as follows. Insoluble fusion protein from washed PBs was brought
into suspension with 10 mM Tris-ClH pH 8. After sonication
(2 sec pulse at 10% for a period of 30 sec), aliquots of this
suspension were withdrawn and maintained on ice for subsequent
analysis of proteins and xylanase activity in the absence of trypsin.
The remaining Zera-Xyl suspension was incubated with trypsin
(T1426 Sigma) at a ratio of 1:200 (w:w) for trypsin:Zera-Xylanase,
at 37uC. Digestion by trypsin was terminated at 0 h, 1 h or 2 h by
the addition of 0.35 mg/ml of Soybean Trypsin Inhibitor (T9003
Sigma). After each incubation period, aliquots were taken for the
analysis of proteins and xylanase activity. Zera-Xyl denatured at
90uC for 20 min was used as the unfolded xylanase control.
Proteins were analyzed in 12% polyacrylamide SDS-PAGE gels.
For measurement of xylanase activity, samples were centrifuged to
recover protein aggregates and suspended in xylanase activity
buffer (200 mM phosphate citrate, pH 6).
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